Abstract
Potassium citrate is a new and exciting therapeutic modality introduced in 1985 for the management of a wide variety of stone-forming disorders. It has reawakened interest in the deranged citrate metabolism in nephrolithiasis and in the physicochemical effects of citrate in stone formation. It has substantially expanded our capability for an effective medical control of stone disease. The approval of this drug in the United States represented a culmination of our seven years of extensive laboratory and clinical work. This chapter will review this work pertaining to: (1) physicochemical action of citrate, (2) physiological effect of potassium citrate, (3) physicochemical effect of potassium citrate, (4) long-term clinical trial with potassium citrate and safety of potassium citrate.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pak, C.Y. C. 1978. Calcium urolithiasis: pathogenesis, diagnosis and management. New York: Plenum Publishing, pp. 5–36.
Pak, C.Y.C., Hayashi, Y., Finlayson, B. and Chu, S. 1977. Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods. J. Lab. Clin. Med. 89:891–901.
Pak, C. Y. C. and Holt, K. 1976. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism 25:665–673.
Pak, C. Y. C. and Galosy, R. A. 1980. Urinary FPR-APR discriminant score for the quantitative assessment of the propensity for spontaneous nucleation of calcium oxalate. Am. J. Med. 69:681–689.
Nicar, M.J., Hill, K. and Pak, C. Y. C. 1983. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation. Metabolism 32:906–910.
Pak, C. Y. C, Sakhaee, K. and Fuller, C. 1986. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int. 30:422–428.
Pak, C. Y. C, Nicar, M. and Northcutt, C. 1982. The definition of the mechanism of hyper-calciuria is necessary for the treatment of recurrent stone formers. In Contributions to Nephrology, G.M. Berlyne, S. Giovannetti and S. Thomas (eds.). Basel: S. Karger, pp. 136–151.
Kok, D.J., Papapoulos, S.E. and Bijvoet, O.L.M. 1986. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1:1056–1058.
Finlayson, B. and Smith, A. 1974. Stability of first dissociable proton of uric acid. J. Chem. Eng. Data. 19:94–97.
Nicar, M.J., Skurla, C, Sakhaee, K. and Pak, C. Y. C. 1983. Low urinary citrate excretion in nephrolithiasis. Urology 21:8–14.
Menon, M. and Mahle, C.J. 1983. Urinary citrate excretion in patients with renal calculi. J. Urol. 129:1158–1160.
Schwille, P.O., Scholz, D., Schwüle, K., Leutschaft, R., Goldberg, I. and Sigel, A. 1982. Citrate in urine and serum and associated variables in subgroups of urolithiasis. Nephron 31:194–202.
Nicar, M.J., Peterson, R. and Pak, C.Y. C. 1984. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J. Urol. 131:430–433.
Pak, C. Y.C., Skurla, C, Brinkley, L. and Sakhaee, K. 1984. Augmentation of renal citrate excretion by oral potassium citrate administration: time course, dose frequency schedule, and dose-response relationship. J. Clin. Pharmacol. 24:19–26.
Sakhaee, K., Nicar, M., Hill, K. and Pak, C.Y. C. 1983. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int. 24:348–352.
Preminger, G. M., Sakhaee, K., Skurla, C. and Pak, C.Y. C. 1985. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J. Urol. 134:20–23.
Pak, C.Y.C., Peterson, R., Sakhaee, K., Fuller, C, Preminger, G. and Reisch, J. 1985. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am. J. Med. 79:284–288.
Nicar, M.J., Hsu, M.C. and Fetner, C. 1986. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting. Clin. Ther. 8:219–225.
Pak, C. Y. C, Fuller, C, Sakhaee, K., Preminger, G. and Britton, F. 1985. Long-term treatment of calcium nephrolithiasis with potassium citrate. J. Urol. 134:11–19.
Yendt, E.R. and Cohanim, M. 1978. Prevention of calcium stones with thiazides. Kidney Int. 13:397–409.
Kassirer, J. P., Berkman, P. M., Lawrenz, D. R. and Schwartz, W. B. 1965. The critical role of chloride in the correction of hypokalemic alkalosis in man. Am. J. Med. 38:172–189.
Pak, C.Y.C. 1985. Renal calculi. In Cecil Textbook of Medicine, J.B. Wyngaarden, L.H. Smith, Jr. and F. Plum (eds.). Philadelphia W.B. Saunders Co., pp. 628–633.
Pak, C.Y.C, Peters, P., Hurt, G., Kadesky, M., Fine, M., Reisman, D., Splann, F., Caramela, C, Freeman, A., Britton, F., Sakhaee, K. and Breslau, N.A. 1981 Is selective therapy of recurrent nephrolithiasis possible? Am. J. Med. 71:615–622.
Pak, C.Y.C. and Fuller, C. 1986. Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate. Ann. Intern. Med. 104:33–37.
Pak, C. Y.C., Britton, F., Peterson, R., Ward, D., Northcutt, C, Breslau, N. A., McGuire, J., Sakhaee, K., Bush, S., Nicar, M., Norman, D.A. and Peters, P. 1980. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am. J. Med. 69:19–30.
Pak, C.Y. C, Holt, K. and Zerwekh, J.E. 1979. Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation. Invest. Urol. 17:138–140.
Pak, C. Y. C. and Peterson, R. 1986. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch. Intern. Med. 146:863–868.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Pak, C.Y.C., Adams, B.V. (1987). Potassium Citrate Therapy of Nephrolithiasis. In: Pak, C.Y.C. (eds) Renal Stone Disease. Topics in Renal Medicine, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2069-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2069-2_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9228-9
Online ISBN: 978-1-4613-2069-2
eBook Packages: Springer Book Archive